Centro de Documentação da PJ
Monografia
 CD112 |
World drug report 2007 [Documento electrónico].- Vienna : United Nations Office on Drugs and Crime (UNODC), 2007.- 1 CD-ROM ; 12 cm
Ficheiro de 7,32 Mb em formato pdf (282 f.). Também disponível em: http://www.unodc.org/pdf/research/wdr07/WDR_2007.pdf.
ISBN 978-92-1-148222-5
TRÁFICO DE DROGA, ROTA DE DROGA, CRIME TRANSNACIONAL, CRIME ORGANIZADO, LABORATÓRIO CLANDESTINO, TRATAMENTO DA TOXICODEPENDÊNCIA, ESTATÍSTICAS SOBRE DROGA, RELATÓRIO
Preface. Introduction. Explanatory notes. Executive Summary. 1. TRENDS IN WORLD DRUG MARKETS. 1.1 Overview. 1.1.1 Global evolution. 1.1.2 Global outlook. 1.2 Opium / Heroin market. 1.2.1 Summary trend / overview. 1.2.2 Production. 1.2.3 Trafficking. 1.2.4 Abuse. 1.3 Coca / Cocaine market. 1.3.1 Summary trend / overview. 1.3.2 Production. 1.3.3 Trafficking. 1.3.4 Abuse. 1.4 Cannabis market. 1.4.1 Summary trend / overview. 1.4.2 Production. 1.4.3 Trafficking. 1.4.4 Abuse. 1.5 Amphetamine-type stimulants market. 1.5.1 Summary trend / overview. 1.5.2 Production. 1.5.3 Trafficking. 1.5.4 Abuse. 2. INVISIBLE EMPIRE OR INVISIBLE HAND? ORGANIZED CRIME AND TRANSNATIONAL DRUG TRAFFICKING. 2.1 Introduction. 2.2 Assessing the degree of organization. 2.3 Cocaine via Central America to the United States. 2.4 Heroin via Central Asia to the Russian Federation. 2.5 Tracking Trafficking. 3. STATISTICAL ANNEX. 3.1 Production. 3.1.1 Afghanistan. 3.1.2 Bolivia. 3.1.3 Colombia. 3.1.4 Lao PDR. 3.1.5 Myanmar. 3.1.6 Peru. 3.2 Seizures. 3.3 Seizures of illicit laboratories. 3.4 Prices. 3.4.1 Opiates: Wholesale, street prices and purity levels. 3.4.2 Cocaine: Wholesale, street prices and purity levels. 3.4.3 Cannabis: Wholesale, street prices and purity levels. 3.4.4 Amphetamine-type stimulants: Wholesale, street prices and purity levels. 3.5 Consumption. 3.5.1 Annual Prevalence. 3.5.1.1 Opiates. 3.5.1.2 Cocaine. 3.5.1.3 Cannabis. 3.5.1.4 Amphetamine-type stimulants (excluding ecstasy). 3.5.1.5 Ecstasy. 3.5.2. Treatment Demand. 3.5.2.1 Primary drugs of abuse among persons treated for drug problems in Africa. 3.5.2.2 Primary drugs of abuse among persons treated for drug problems in America. 3.5.2.3 Primary drugs of abuse among persons treated for drug problems in Asia. 3.5.2.4 Primary drugs of abuse among persons treated
for drug problems in Europe. 3.5.2.5 Primary drugs of abuse among persons treated for drug problems in Oceania. 4. METHODOLOGY.